Steady-State Pharmacokinetics of a Novel Extended-Release Metformin Formulation

By Timmins Peter  

Clinical Pharmacokinetics, Vol. 44, Iss. 7, 2005-01 ,pp. : 721-729

Adis International

Access to resources Recommend Favorite

Functional Half-Life is a Meaningful Descriptor of Steady-State Pharmacokinetics of an Extended-Release Formulation of a Rapidly Cleared Drug: As Shown by Once-Daily Divalproex-ER

By Dutta Sandeep   Reed Ronald C.  

Clinical Drug Investigation, Vol. 26, Iss. 12, 2006-01 ,pp. : 681-690

Adis International

Access to resources Recommend Favorite

Clinical Pharmacokinetics and Gastrointestinal Tolerability of a Novel Extended-Release Microsphere Formulation of Azithromycin

By Chandra Richa   Liu Ping   Breen Jeanne D.   Fisher Jeannine   Xie Charles   LaBadie Robert   Benner Rebecca J.   Benincosa Lisa J.   Sharma Amarnath  

Clinical Pharmacokinetics, Vol. 46, Iss. 3, 2007-01 ,pp. : 247-259

Adis International

Access to resources Recommend Favorite

An extended-release formulation of desferrioxamine for subcutaneous administration

By Toliyat Tayebeh   Jorjani Masomeh   Khorasanirad Zeinab  

Drug Delivery, Vol. 16, Iss. 7, 2009-10 ,pp. : 416-421

Informa Healthcare

Access to resources Recommend Favorite

Pharmacokinetics of a Novel Anagrelide Extended‐Release Formulation in Healthy Subjects: Food Intake and Comparison With a Reference Product

By  

Clinical Pharmacology In Drug Development, Vol. 7, Iss. 2, 2018-02 ,pp. : 123-131

John Wiley & Sons Inc

Access to resources Recommend Favorite